PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy

NCT04538950 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Cancer

Interventions

DIAGNOSTIC_TEST: PET/CT
DRUG: radioactive drug (tracer)

Sponsor

Mayo Clinic